ArticleCancers2021

Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma.

Celina L Szanto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.